Table 3.
Correlation between CEA-response and second RECIST-response
| Second RECIST-response | In RECIST-CR patients |
In RECIST-PR patients |
In RECIST-SD patients |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Non-PD (n=9) | PD (n=2) | p-value | Non-PD (n=140) | PD (n=28) | p-value | Non-PD (n=85) | PD (n=29) | p-value | |
| CEA-response | |||||||||
| CEA-CR | 3 (100) | 0 | 0.113 | 33 (91.7) | 3 (8.3) | < 0.001 | 7 (100) | 1 (10) | < 0.001 |
| CEA-PR | 3 (100) | 0 | 67 (87.0) | 10 (13.0) | 31 (88.6) | 4 (11.4) | |||
| CEA-SD | 2 (66.7) | 1 (33.3) | 29 (82.9) | 6 (17.1) | 33 (73.3) | 12 (26.7) | |||
| CEA-PD | 1 (50.0) | 1 (50.0) | 11 (55.5) | 9 (45.0) | 14 (51.9) | 13 (48.1) | |||
Values are presented as number (%). CEA, carcinoembryonic antigen; RECIST, Response Evaluation Criteria in Solid Tumors; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.